The global coronary stents market was valued at USD 6.68 billion in 2024 and is expected to grow to USD 10.66 billion by 2032, reflecting a compound annual growth rate (CAGR) of 6.2% during the forecast period. In 2024, North America held the leading position in the market, accounting for a 33.08% share.
The coronary stents market plays a vital role in the treatment of coronary artery disease, offering minimally invasive solutions to restore blood flow in blocked or narrowed arteries. These small, expandable devices are widely used in angioplasty procedures to support arterial walls and reduce the risk of future blockages. With the increasing prevalence of cardiovascular diseases, changing lifestyles, and advancements in interventional cardiology, demand for coronary stents continues to grow. Innovations such as drug-eluting stents, bioresorbable stents, and improved stent delivery systems are enhancing clinical outcomes and patient recovery. As healthcare systems prioritize faster, safer, and more effective treatment options, the coronary stents market is poised for continued evolution and global expansion.
Continue reading for more details:
**https://www.fortunebusinessinsights.com/industry-reports/coronary-stents-market-100065**
Coronary Stents Market Overview & Key Metrics
Market Size & Forecast:
- 2024 Market Size: USD 6.68 billion
- 2025 Market Size: USD 7.02 billion
- 2032 Forecast Market Size: USD 10.66 billion
- CAGR: 6.2% from 2025–2032
Market Share:
- North America dominated the coronary stents market with a 33.08% share in 2024, driven by a robust healthcare infrastructure, high CAD prevalence, and frequent product launches backed by regulatory approvals in the U.S.
- By stent type, drug-eluting stents (DES) are projected to maintain the largest market share in 2025, due to growing clinical demand, increasing launches, and regulatory approvals. Their ability to reduce restenosis rates contributes to widespread clinical preference.
Key Country Highlights:
- Japan: Growth is supported by an aging population susceptible to CAD, growing hospital infrastructure, and regulatory support for advanced coronary devices. The presence of local players like Terumo fosters product accessibility.
- United States: High disease burden, advanced cardiac care centers, and product innovations by key players (e.g., Abbott, Medtronic) contribute to increased adoption. Regulatory approvals, like the FDA clearance of new DES systems, also accelerate market growth.
- China: Rising CAD prevalence, increasing awareness, and the expansion of specialty hospitals and catheterization labs are key growth drivers. Domestic manufacturers like MicroPort are expanding rapidly with government approvals, including NMPA authorization for bioresorbable stents.
- Europe: Market growth is supported by CE-mark approvals and increasing preference for PCI procedures. Countries like Germany and the U.K. are expanding their interventional cardiology services, and major players are launching advanced DES platforms in the region.